Stock Analysis of Qsam Biosciences Inc (QSAM) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code QSAM
Close 8.30
Change 0.550 / 7.10 %
Volume 133563
Vol Change 97082.00 / 266.12 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Qsam Biosciences Inc
PE (TTM)

-5.01

Very Poor
Price / Book

-49.99

Very Poor
Price / Sales

0

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

18442.60

Enterprise Value

-1378.89 B

ROA (TTM)

-576.91

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

16.29 %

-5085.07 K
Debt to Equity

0.0460

Excellent
Altman Z Score

-33.04

Very Poor
Quick Ratio

0

Poor
Cash Ratio

1.34

Indecisive


Highs/Lows of Qsam Biosciences Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week8.09 2.60 % 1.54 % 8.47.729-Apr-2401-May-24
Two Week7.78 6.68 % 3.42 % 8.47.729-Apr-2401-May-24
One Month7.4 12.16 % 5.60 % 8.47.1529-Apr-2411-Apr-24
Three Month5.35 55.14 % 5.95 % 8.45.129-Apr-2407-Feb-24
Six Months5.2 59.62 % 17.48 % 8.44.9829-Apr-2403-Nov-23
One year5.975 38.91 % 27.52 % 8.44.029-Apr-2408-May-23
Two year5.8 43.10 % 29.70 % 8.43.5129-Apr-2420-Mar-23
Five year0.375 2113.33 % 85.46 % 8.40.127529-Apr-2430-Dec-19
Ten year19.5 57.44 % 182.41 % 68.750.127504-May-1530-Dec-19


Technical View of Qsam Biosciences Inc
RSI

68.69

Neutral
MACD

0.225

Mild Bearish
ADX

24.43

Neutral
Super Trend

8.38

Bearish
Williams %R

-9.01

Mild Bearish
CCI

82.56

Neutral


EMA 5

8.02

Bullish
EMA 15

7.87

Neutral
EMA 50

7.35

Bullish
EMA 100

6.82

Strong Bullish
SMA 100

6.67

Strong Bullish
SMA 200

5.84

Strong Bullish
SMA 5 / 20

7.97 / 7.73

Bullish
SMA 15 / 50

7.86 / 7.33

Strong Bullish
SMA 50 / 200

7.33 / 5.84

Strong Bullish




Charts of Qsam Biosciences Inc


Returns of Qsam Biosciences Inc with Peers
Period / StockQSAMCALASTABSCPSHGEN
1 Week2.60%0%0%83.33%-83.33%
1 Mth12.16%-60.00%16.67%83.33%-96.00%
3 Mth55.14%-71.43%-97.57%-69.44%-98.60%
6mth59.62%-71.43%-97.57%-97.41%-99.87%
1 Year38.91%-20.00%-96.67%-98.43%-99.88%
2 Year43.10%-99.53%-99.72%-99.73%-99.99%
5 Years2113.33%-99.98%-99.96%--99.99%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Qsam Biosciences Inc with Peers
Ratio / StockQSAMCALASTABSCPSHGEN
PE-5.01-0.0029-0.0002-0.730-0.057
P/B-49.990.00310.0021-0.861-0.133
ROA-576.91-60.10-513.42-1183.25-322.06
ROE0-155.85-1395.8200
Debt To Equity0.04600.075-3.0800
Revenue0
% 		0
100.00 % 		1487.04 K
% 		0
% 		2514.00 K
30.07 %
Net Income-5085.07 K
16.29 % 		-21290.00 K
81.50 % 		-101850.82 K
0 % 		-11609.83 K
56.93 % 		-70730.00 K
70.11 %


Technicals of Qsam Biosciences Inc with Peers
Technical / StockQSAMCALASTABSCPSHGEN-
ADX24.4314.3849.4328.1049.19
CMF0.4950.1880.1170.0990.072
MFI66.663.900.009224.2385.06
RSI68.6936.7426.8831.0137.55
MACD Abv SignalFalseTrueTrueTrueTrue
Price Above 50 MATrueFalseTrueFalseFalse-
Price Above 200 MATrueFalseFalseFalseFalse-


About : Qsam Biosciences Inc

Address : Plaza 1, Austin, TX, United States, 78759
Tel : 512 343 4558
URL : https://qsambio.com
Code : QSAM, ISIN : US74738N1037, Exchange : OTCQB, Country : USA
Fiscal Year End : December
IPO date : 11_Dec_2015
Employee Count : 4

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas. As of May 3, 2024, QSAM Biosciences, Inc. operates as a subsidiary of Telix Pharmaceuticals (Us) Inc.


Note : All Data Generated at the End of Trading Hours (EOD Data)